This is in line with our results showing increased interstitial fibrosis and tubular atrophy, a lower eGFR, as well as a worse CKD prognosis with a higher FGL2 mRNA expression level in kidney biopsies. The gene discussed is FGL2; the disease is chronic kidney disease.